Fiduciary Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$546K Sell
7,289
-892
-11% -$70.6K 0.01% 545
2026
Q2
$646K Buy
8,181
+575
+8% +$48.9K 0.01% 521
2026
Q1
$655K Buy
7,606
+17
+0.2% +$1.53K 0.01% 508
2025
Q4
$663K Sell
7,589
-1,008
-12% -$76.5K 0.01% 490
2025
Q3
$492K Buy
8,597
+563
+7% +$32.4K 0.01% 565
2025
Q2
$474K Buy
8,034
+450
+6% +$29.1K 0.01% 546
2025
Q1
$555K Buy
+7,584
New +$627K 0.01% 506

Other funds holding GMED

Fiduciary Trust's GMED Position: Q3 2026 in Review

Fiduciary Trust reduced its Globus Medical (GMED) stake by 11% in Q3 2026, selling an estimated $70.6K and leaving 7,289 shares worth $546K. The position accounts for 0.01% of the portfolio, ranked #545.

Fiduciary Trust first reported a position in GMED in Q1 2025 and has held it in 7 quarters since. The position peaked at $663K in Q4 2025. 617 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Fiduciary Trust held 7,289 shares of Globus Medical worth $546K as of Q3 2026.
  • Fiduciary Trust sold 892 Globus Medical shares in Q3 2026, an estimated $70.6K.
  • Globus Medical made up 0.01% of Fiduciary Trust's portfolio in Q3 2026, its #545 holding.
  • Fiduciary Trust first reported a position in Globus Medical in Q1 2025 and has held it in 7 quarters since.
  • Fiduciary Trust's Globus Medical position peaked at $663K in Q4 2025.
  • 617 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Fiduciary Trust's 13F filing for Q3 2026, filed 16 Nov 2026.